SIBUTRAL Side Effects

6710543-3 | Hemianopia Homonymous
on Apr 26, 2010 Female patient from FRANCE , weighting 138.9 lb, was diagnosed with headache (What is headache?) and was treated with Sibutral (View Usage). Patient experienced the following unwanted or unexpected effects: hemianopia homonymous. Sibutral dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), BALSOFUMINE (View Balsofumine Review and Balsofumine Label ). Patient was hospitalized.

6138128-0 | Abdominal Pain, Retroperitoneal Fibrosis
Patient was taking Sibutral (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), retroperitoneal fibrosis on Mar 26, 2009 from FRANCE Additional patient health information: Female patient , weighting 207.2 lb, was diagnosed with overweight and. Sibutral dosage: . During the same period patient was treated with DEMINTEL (During At Least 2 Years, More Than 15 To 20 Years Ago) (View Demintel Review and Demintel Label ), DONORMYL (View Donormyl Review and Donormyl Label ), XENICAL (View Xenical Review and Xenical Label ), LEVOTHYROXINE SODIUM (75 To 150 Mcg/ Day, Long Term Treatment) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

5685079-1 | Abortion Spontaneous
Adverse event was reported on Mar 26, 2008 by a Female patient taking Sibutral (View Usage) (Dosage: ) was diagnosed with weight control (What is weight control?) and. Location: FRANCE , 33 years of age, weighting 246.9 lb, After Sibutral was administered, patient had the following side effects: abortion spontaneous.

5419024-0 | Angioedema, Blood Corticotrophin Increased, Blood Pressure Decreased, Body Temperature, Cytolytic Hepatitis, Face Oedema, Glucose Tolerance Impaired, Loss Of Consciousness, Malaise
on Aug 08, 2007 Female patient from FRANCE , 27 years of age, weighting 221.1 lb, was diagnosed with obesity (What is obesity?), menstrual disorder, gastritis and was treated with Sibutral (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, blood corticotrophin increased, blood pressure decreased, body temperature, cytolytic hepatitis, face oedema, glucose tolerance impaired, loss of consciousness, malaise. Sibutral dosage: . During the same period patient was treated with BENFLUOREX HYDROCHLORIDE (View Benfluorex Hydrochloride Review and Benfluorex Hydrochloride Label ), SPASFON (View Spasfon Review and Spasfon Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ETHINYL ESTRADIOL W/NORGESTREL (View Ethinyl Estradiol W/norgestrel Review and Ethinyl Estradiol W/norgestrel Label ), METFORMINE (View Metformine Review and Metformine Label ). Patient was hospitalized.


5374762-3 | Erectile Dysfunction, Weight Increased
on Jun 22, 2007 Male patient from FRANCE , weighting 187.4 lb, was diagnosed with obesity (What is obesity?), familial risk factor and was treated with Sibutral (View Usage). Patient had the following side effects: erectile dysfunction (What is erectile dysfunction?), weight increased. Sibutral dosage: . During the same period patient was treated with ORLISTAT (View Orlistat Review and Orlistat Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

5297189-1 | Angioedema, Blood Corticotrophin Increased, Blood Pressure Decreased, Body Temperature, Cytolytic Hepatitis, Face Oedema, Glucose Tolerance Impaired, Loss Of Consciousness, Malaise
Patient was taking Sibutral (View Usage). After Sibutral was administered, patient had the following side effects: angioedema, blood corticotrophin increased, blood pressure decreased, body temperature, cytolytic hepatitis, face oedema, glucose tolerance impaired, loss of consciousness, malaise on Apr 05, 2007 from FRANCE Additional patient health information: Female patient , 27 years of age, weighting 221.1 lb, was diagnosed with obesity (What is obesity?), menstrual disorder, gastritis and. Sibutral dosage: . During the same period patient was treated with BENFLUOREX HYDROCHLORIDE (View Benfluorex Hydrochloride Review and Benfluorex Hydrochloride Label ), SPASFON (View Spasfon Review and Spasfon Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ETHINYL ESTRADIOL W/NORGESTREL (View Ethinyl Estradiol W/norgestrel Review and Ethinyl Estradiol W/norgestrel Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5286957-8 | Angioedema, Blood Corticotrophin Increased, Blood Pressure Decreased, Body Temperature, Cytolytic Hepatitis, Face Oedema, Glucose Tolerance Impaired, Loss Of Consciousness, Malaise
Adverse event was reported on Mar 28, 2007 by a Female patient taking Sibutral (View Usage) (Dosage: ) was diagnosed with menstrual disorder, gastritis and. Location: FRANCE , 27 years of age, weighting 221.1 lb, Patient experienced the following unwanted or unexpected effects: angioedema, blood corticotrophin increased, blood pressure decreased, body temperature, cytolytic hepatitis, face oedema, glucose tolerance impaired, loss of consciousness, malaise. During the same period patient was treated with BENFLUOREX HYDROCHLORIDE (View Benfluorex Hydrochloride Review and Benfluorex Hydrochloride Label ), SPASFON (View Spasfon Review and Spasfon Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ETHINYL ESTRADIOL W/NORGESTREL (View Ethinyl Estradiol W/norgestrel Review and Ethinyl Estradiol W/norgestrel Label ). Patient was hospitalized.

5275011-7 | Angioedema, Blood Corticotrophin Increased, Blood Pressure Decreased, Body Temperature, Cytolytic Hepatitis, Face Oedema, Glucose Tolerance Impaired, Loss Of Consciousness, Malaise
on Mar 14, 2007 Female patient from FRANCE , 27 years of age, weighting 221.1 lb, was diagnosed with menstrual disorder, gastritis and was treated with Sibutral (View Usage). Patient had the following side effects: angioedema, blood corticotrophin increased, blood pressure decreased, body temperature, cytolytic hepatitis, face oedema, glucose tolerance impaired, loss of consciousness, malaise. Sibutral dosage: . During the same period patient was treated with BENFLUOREX HYDROCHLORIDE (View Benfluorex Hydrochloride Review and Benfluorex Hydrochloride Label ), SPASFON (View Spasfon Review and Spasfon Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ETHINYL ESTRADIOL W/NORGESTREL (View Ethinyl Estradiol W/norgestrel Review and Ethinyl Estradiol W/norgestrel Label ). Patient was hospitalized.

5226285-X | Multi-organ Failure
on Jan 23, 2007 Male patient from FRANCE , 72 years of age, was treated with Sibutral (View Usage). After Sibutral was administered, patient had the following side effects: multi-organ failure. Sibutral dosage: . Patient was hospitalized.

4929976-0 | Aortic Valve Stenosis, Dyspnoea, Echocardiogram Abnormal, Mitral Valve Incompetence, Pulmonary Hypertension
Patient was taking Sibutral (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve stenosis, dyspnoea, echocardiogram abnormal, mitral valve incompetence, pulmonary hypertension (What is pulmonary hypertension?) on Jul 24, 2002 from FRANCE Additional patient health information: Female patient , 63 years of age, weighting 255.7 lb, was diagnosed with obesity (What is obesity?) and. Sibutral dosage: . During the same period patient was treated with DEXFENFLURAMINE HYDROCHLORIDE (View Dexfenfluramine Hydrochloride Review and Dexfenfluramine Hydrochloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), RILMENIDINE (View Rilmenidine Review and Rilmenidine Label ), DIGITOXIN TAB (View Digitoxin Tab Review and Digitoxin Tab Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

4890130-2 | Chills, Dizziness, Gait Disturbance, Headache, Hyperhidrosis, Malaise, Nausea, Serotonin Syndrome
Adverse event was reported on Jan 16, 2006 by a Female patient taking Sibutral (View Usage) (Dosage: ) . Location: FRANCE , 19 years of age, Patient had the following side effects: chills, dizziness (What is dizziness?), gait disturbance, headache (What is headache?), hyperhidrosis, malaise, nausea (What is nausea?), serotonin syndrome. During the same period patient was treated with SERTRALINE (View Sertraline Review and Sertraline Label ). Patient was hospitalized.

4864573-7 | Abortion Induced, Cerebellar Tumour, Congenital Anomaly, Pregnancy
on Jan 28, 2003 Female patient from FRANCE , weighting 203.3 lb, was diagnosed with obesity (What is obesity?) and was treated with Sibutral (View Usage). After Sibutral was administered, patient had the following side effects: abortion induced, cerebellar tumour, congenital anomaly, pregnancy (What is pregnancy?). Sibutral dosage: .

4565844-4 | Pulmonary Embolism
on Jan 21, 2005 Female patient from , 47 years of age, was diagnosed with contraception and was treated with Sibutral (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Sibutral dosage: . During the same period patient was treated with ETHINYLESTRADIOL W/LEVONORGESTREL (View Ethinylestradiol W/levonorgestrel Review and Ethinylestradiol W/levonorgestrel Label ). Patient was hospitalized.